Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 16 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.

According to our (Global Info Research) latest study, the global Contrast Agents for Magnetic Resonance Imaging (MRI) market size was valued at USD 1425 million in 2022 and is forecast to a readjusted size of USD 1963.9 million by 2029 with a CAGR of 4.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.

In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.

This report is a detailed and comprehensive analysis for global Contrast Agents for Magnetic Resonance Imaging (MRI) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Contrast Agents for Magnetic Resonance Imaging (MRI) market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Contrast Agents for Magnetic Resonance Imaging (MRI) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Contrast Agents for Magnetic Resonance Imaging (MRI) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Contrast Agents for Magnetic Resonance Imaging (MRI) market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Contrast Agents for Magnetic Resonance Imaging (MRI)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Contrast Agents for Magnetic Resonance Imaging (MRI) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France) and Lantheus (US), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Contrast Agents for Magnetic Resonance Imaging (MRI) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Barium-based Contrast Media
    Iodinated Contrast Media
    Gadolinium-based Contrast Media
    Microbubble Contrast Media

Market segment by Application
    Radiology
    Interventional Radiology
    Interventional Cardiology

Major players covered
    GE Healthcare (US)
    Bracco Imaging (Italy)
    Bayer HealthCare (Germany)
    Guerbet (France)
    Lantheus (US)
    Daiichi Sankyo (Japan)
    Unijules Life Sciences (India)
    J.B. Chemicals and Pharmaceuticals (India)
    Spago Nanomedicine (Sweden)
    Taejoon Pharm (South Korea)
    Jodas (India)
    Magnus Health (India)

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Contrast Agents for Magnetic Resonance Imaging (MRI) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI), with price, sales, revenue and global market share of Contrast Agents for Magnetic Resonance Imaging (MRI) from 2018 to 2023.
Chapter 3, the Contrast Agents for Magnetic Resonance Imaging (MRI) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Contrast Agents for Magnetic Resonance Imaging (MRI) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Contrast Agents for Magnetic Resonance Imaging (MRI) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Contrast Agents for Magnetic Resonance Imaging (MRI).
Chapter 14 and 15, to describe Contrast Agents for Magnetic Resonance Imaging (MRI) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Contrast Agents for Magnetic Resonance Imaging (MRI)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Barium-based Contrast Media
        1.3.3 Iodinated Contrast Media
        1.3.4 Gadolinium-based Contrast Media
        1.3.5 Microbubble Contrast Media
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Radiology
        1.4.3 Interventional Radiology
        1.4.4 Interventional Cardiology
    1.5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size & Forecast
        1.5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (2018-2029)
        1.5.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 GE Healthcare (US)
        2.1.1 GE Healthcare (US) Details
        2.1.2 GE Healthcare (US) Major Business
        2.1.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.1.4 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 GE Healthcare (US) Recent Developments/Updates
    2.2 Bracco Imaging (Italy)
        2.2.1 Bracco Imaging (Italy) Details
        2.2.2 Bracco Imaging (Italy) Major Business
        2.2.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.2.4 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Bracco Imaging (Italy) Recent Developments/Updates
    2.3 Bayer HealthCare (Germany)
        2.3.1 Bayer HealthCare (Germany) Details
        2.3.2 Bayer HealthCare (Germany) Major Business
        2.3.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.3.4 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Bayer HealthCare (Germany) Recent Developments/Updates
    2.4 Guerbet (France)
        2.4.1 Guerbet (France) Details
        2.4.2 Guerbet (France) Major Business
        2.4.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.4.4 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Guerbet (France) Recent Developments/Updates
    2.5 Lantheus (US)
        2.5.1 Lantheus (US) Details
        2.5.2 Lantheus (US) Major Business
        2.5.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.5.4 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Lantheus (US) Recent Developments/Updates
    2.6 Daiichi Sankyo (Japan)
        2.6.1 Daiichi Sankyo (Japan) Details
        2.6.2 Daiichi Sankyo (Japan) Major Business
        2.6.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.6.4 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Daiichi Sankyo (Japan) Recent Developments/Updates
    2.7 Unijules Life Sciences (India)
        2.7.1 Unijules Life Sciences (India) Details
        2.7.2 Unijules Life Sciences (India) Major Business
        2.7.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.7.4 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Unijules Life Sciences (India) Recent Developments/Updates
    2.8 J.B. Chemicals and Pharmaceuticals (India)
        2.8.1 J.B. Chemicals and Pharmaceuticals (India) Details
        2.8.2 J.B. Chemicals and Pharmaceuticals (India) Major Business
        2.8.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.8.4 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments/Updates
    2.9 Spago Nanomedicine (Sweden)
        2.9.1 Spago Nanomedicine (Sweden) Details
        2.9.2 Spago Nanomedicine (Sweden) Major Business
        2.9.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.9.4 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Spago Nanomedicine (Sweden) Recent Developments/Updates
    2.10 Taejoon Pharm (South Korea)
        2.10.1 Taejoon Pharm (South Korea) Details
        2.10.2 Taejoon Pharm (South Korea) Major Business
        2.10.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.10.4 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Taejoon Pharm (South Korea) Recent Developments/Updates
    2.11 Jodas (India)
        2.11.1 Jodas (India) Details
        2.11.2 Jodas (India) Major Business
        2.11.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.11.4 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Jodas (India) Recent Developments/Updates
    2.12 Magnus Health (India)
        2.12.1 Magnus Health (India) Details
        2.12.2 Magnus Health (India) Major Business
        2.12.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
        2.12.4 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Magnus Health (India) Recent Developments/Updates

3 Competitive Environment: Contrast Agents for Magnetic Resonance Imaging (MRI) by Manufacturer
    3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturer (2018-2023)
    3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Contrast Agents for Magnetic Resonance Imaging (MRI) by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturer Market Share in 2022
        3.4.2 Top 6 Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturer Market Share in 2022
    3.5 Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Overall Company Footprint Analysis
        3.5.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Region Footprint
        3.5.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Company Product Type Footprint
        3.5.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Region
        4.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Region (2018-2029)
        4.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Region (2018-2029)
        4.1.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Region (2018-2029)
    4.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value (2018-2029)
    4.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value (2018-2029)
    4.4 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value (2018-2029)
    4.5 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value (2018-2029)
    4.6 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2029)
    5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Type (2018-2029)
    5.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2029)
    6.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Application (2018-2029)
    6.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Application (2018-2029)

7 North America
    7.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2029)
    7.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2029)
    7.3 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
        7.3.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Country (2018-2029)
        7.3.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2029)
    8.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2029)
    8.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
        8.3.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Country (2018-2029)
        8.3.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Region
        9.3.1 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2029)
    10.2 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2029)
    10.3 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
        10.3.1 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Country (2018-2029)
        10.3.2 South America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
        11.3.1 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Drivers
    12.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Restraints
    12.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Contrast Agents for Magnetic Resonance Imaging (MRI) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Contrast Agents for Magnetic Resonance Imaging (MRI)
    13.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Production Process
    13.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Typical Distributors
    14.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. GE Healthcare (US) Basic Information, Manufacturing Base and Competitors
    Table 4. GE Healthcare (US) Major Business
    Table 5. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 6. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. GE Healthcare (US) Recent Developments/Updates
    Table 8. Bracco Imaging (Italy) Basic Information, Manufacturing Base and Competitors
    Table 9. Bracco Imaging (Italy) Major Business
    Table 10. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 11. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Bracco Imaging (Italy) Recent Developments/Updates
    Table 13. Bayer HealthCare (Germany) Basic Information, Manufacturing Base and Competitors
    Table 14. Bayer HealthCare (Germany) Major Business
    Table 15. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 16. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Bayer HealthCare (Germany) Recent Developments/Updates
    Table 18. Guerbet (France) Basic Information, Manufacturing Base and Competitors
    Table 19. Guerbet (France) Major Business
    Table 20. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 21. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Guerbet (France) Recent Developments/Updates
    Table 23. Lantheus (US) Basic Information, Manufacturing Base and Competitors
    Table 24. Lantheus (US) Major Business
    Table 25. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 26. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Lantheus (US) Recent Developments/Updates
    Table 28. Daiichi Sankyo (Japan) Basic Information, Manufacturing Base and Competitors
    Table 29. Daiichi Sankyo (Japan) Major Business
    Table 30. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 31. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Daiichi Sankyo (Japan) Recent Developments/Updates
    Table 33. Unijules Life Sciences (India) Basic Information, Manufacturing Base and Competitors
    Table 34. Unijules Life Sciences (India) Major Business
    Table 35. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 36. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Unijules Life Sciences (India) Recent Developments/Updates
    Table 38. J.B. Chemicals and Pharmaceuticals (India) Basic Information, Manufacturing Base and Competitors
    Table 39. J.B. Chemicals and Pharmaceuticals (India) Major Business
    Table 40. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 41. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. J.B. Chemicals and Pharmaceuticals (India) Recent Developments/Updates
    Table 43. Spago Nanomedicine (Sweden) Basic Information, Manufacturing Base and Competitors
    Table 44. Spago Nanomedicine (Sweden) Major Business
    Table 45. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 46. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Spago Nanomedicine (Sweden) Recent Developments/Updates
    Table 48. Taejoon Pharm (South Korea) Basic Information, Manufacturing Base and Competitors
    Table 49. Taejoon Pharm (South Korea) Major Business
    Table 50. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 51. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Taejoon Pharm (South Korea) Recent Developments/Updates
    Table 53. Jodas (India) Basic Information, Manufacturing Base and Competitors
    Table 54. Jodas (India) Major Business
    Table 55. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 56. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Jodas (India) Recent Developments/Updates
    Table 58. Magnus Health (India) Basic Information, Manufacturing Base and Competitors
    Table 59. Magnus Health (India) Major Business
    Table 60. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product and Services
    Table 61. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Magnus Health (India) Recent Developments/Updates
    Table 63. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Manufacturer (2018-2023) & (K Pcs)
    Table 64. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 65. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Manufacturer (2018-2023) & (USD/Pcs)
    Table 66. Market Position of Manufacturers in Contrast Agents for Magnetic Resonance Imaging (MRI), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 67. Head Office and Contrast Agents for Magnetic Resonance Imaging (MRI) Production Site of Key Manufacturer
    Table 68. Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Company Product Type Footprint
    Table 69. Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Company Product Application Footprint
    Table 70. Contrast Agents for Magnetic Resonance Imaging (MRI) New Market Entrants and Barriers to Market Entry
    Table 71. Contrast Agents for Magnetic Resonance Imaging (MRI) Mergers, Acquisition, Agreements, and Collaborations
    Table 72. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Region (2018-2023) & (K Pcs)
    Table 73. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Region (2024-2029) & (K Pcs)
    Table 74. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Region (2018-2023) & (USD Million)
    Table 75. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Region (2024-2029) & (USD Million)
    Table 76. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Region (2018-2023) & (USD/Pcs)
    Table 77. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Region (2024-2029) & (USD/Pcs)
    Table 78. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 79. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 80. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Type (2018-2023) & (USD/Pcs)
    Table 83. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Type (2024-2029) & (USD/Pcs)
    Table 84. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 85. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 86. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Application (2018-2023) & (USD/Pcs)
    Table 89. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Application (2024-2029) & (USD/Pcs)
    Table 90. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 91. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 92. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 93. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 94. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Country (2018-2023) & (K Pcs)
    Table 95. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Country (2024-2029) & (K Pcs)
    Table 96. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 99. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 100. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 101. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 102. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Country (2018-2023) & (K Pcs)
    Table 103. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Country (2024-2029) & (K Pcs)
    Table 104. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 107. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 108. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 109. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 110. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Region (2018-2023) & (K Pcs)
    Table 111. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Region (2024-2029) & (K Pcs)
    Table 112. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Region (2018-2023) & (USD Million)
    Table 113. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Region (2024-2029) & (USD Million)
    Table 114. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 115. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 116. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 117. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 118. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Country (2018-2023) & (K Pcs)
    Table 119. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Country (2024-2029) & (K Pcs)
    Table 120. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Country (2018-2023) & (USD Million)
    Table 121. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Country (2024-2029) & (USD Million)
    Table 122. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 123. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 124. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 125. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 126. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Region (2018-2023) & (K Pcs)
    Table 127. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity by Region (2024-2029) & (K Pcs)
    Table 128. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Region (2018-2023) & (USD Million)
    Table 129. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Region (2024-2029) & (USD Million)
    Table 130. Contrast Agents for Magnetic Resonance Imaging (MRI) Raw Material
    Table 131. Key Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI) Raw Materials
    Table 132. Contrast Agents for Magnetic Resonance Imaging (MRI) Typical Distributors
    Table 133. Contrast Agents for Magnetic Resonance Imaging (MRI) Typical Customers
List of Figures
    Figure 1. Contrast Agents for Magnetic Resonance Imaging (MRI) Picture
    Figure 2. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value Market Share by Type in 2022
    Figure 4. Barium-based Contrast Media Examples
    Figure 5. Iodinated Contrast Media Examples
    Figure 6. Gadolinium-based Contrast Media Examples
    Figure 7. Microbubble Contrast Media Examples
    Figure 8. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value Market Share by Application in 2022
    Figure 10. Radiology Examples
    Figure 11. Interventional Radiology Examples
    Figure 12. Interventional Cardiology Examples
    Figure 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity (2018-2029) & (K Pcs)
    Figure 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price (2018-2029) & (USD/Pcs)
    Figure 17. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Contrast Agents for Magnetic Resonance Imaging (MRI) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Type (2018-2029) & (USD/Pcs)
    Figure 32. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Average Price by Application (2018-2029) & (USD/Pcs)
    Figure 35. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Drivers
    Figure 76. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Restraints
    Figure 77. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) in 2022
    Figure 80. Manufacturing Process Analysis of Contrast Agents for Magnetic Resonance Imaging (MRI)
    Figure 81. Contrast Agents for Magnetic Resonance Imaging (MRI) Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)

Related Reports

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Supply, Demand and Key Producers, 2023-2029

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Supply, Demand and Key Producers, 2023-2029

date 07 Feb 2023

date Pharma & Healthcare

MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Contrast Agents for Magnetic Resonance Imaging (MRI) market size was valued at USD 1425 million in 2023 and is forecast to a readjusted size of USD 1963.9 million by 2030 with a CAGR of 4.7% during review period.

Product Tags

Contrast Agents for Magnetic Resonance Imaging (MRI)

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>